XBT PROVIDER AB: FURTHER UPDATE WITH REGARD TO DISTRIBUTION

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
527
XBT PROVIDER AB: FURTHER UPDATE WITH REGARD TO DISTRIBUTION OF BITCOIN CASH PROCEEDS

STOCKHOLM, NOVEMBER 20, 2017 - Further to its Press Release of November 9th, XBT Provider AB (Publ) (the "Issuer") wishes to HEREBY CONFIRM that applications in respect of the distribution of the proceeds from the sale of Bitcoin Cash may be submitted with effect from 7am (GMT) on Tuesday, November 21st,  2017. 

Certificate holders who are entitled to distribution of proceeds in accordance with the terms outlined in the Issuer's previous Press Releases on this matter (which may be found here and here ), may submit their application for a distribution via the dedicated portal: https://claims.xbtprovider.com/  

This portal will remain accessible for 3 months, closing at midnight (GMT) on February 19th, 2018. All claims must therefore be submitted before February 20th, 2018.

It is intended that distributions in respect of all approved applications will be made on or before March 20th, 2018.

The Issuer reiterates that only those investors which held Certificates issued by it (and referenced to bitcoin) as at the opening of trading on August 1st, are eligible to make an application for a distribution. If a nominee held title on your behalf and you would wish for an application to be made, please contact such nominee: the Issuer cannot liaise on your behalf with such nominee. (Please also note that the Issuer can provide no assurance as to whether a nominee would be willing or able to comply with your request to make an application and will not be responsible should the nominee not do so).

Representatives of the Issuer have appointed JTC Fund Solutions (Jersey) Limited in Jersey, Channel Islands ("JTC"), to be responsible for the independent administration of the application process. JTC is regulated by the Jersey Financial Services Commission in respect of the conduct of certain classes of fund services and trust company business.

For further information regarding eligibility and documents needed for an application, and for any additional questions or inquiries, please refer to the dedicated portal: https://claims.xbtprovider.com/ 

###

ABOUT THE ISSUER XBT Provider AB (Publ), a CoinShares company, is the Swedish-domiciled issuer of Bitcoin Tracker One and Bitcoin Tracker Euro (COINXBT:SS, COINXBE:SS, respectively) and Ether Tracker One and Ether Tracker Euro (COINETH:SS and COINETHE:SS). These trackers are designed to mirror the return of the underlying asset, bitcoin (in Swedish Kronor and Euro, respectively). In 2015, Bitcoin Tracker One became the first bitcoin-referenced security available on a regulated exchange when it listed on NASDAQ in Stockholm. In 2017, Ether Tracker One became the first ether-referenced security available on a regulated exchange when it listed on NASDAQ in Stockholm. All four certificates are traded in the same manner as any other share or instrument listed on the Nasdaq exchange in Stockholm. The Issuer's Prospectus is approved by the Swedish FSA (Finansinspektionen) and its products are listed on Nasdaq Nordic in Stockholm. XBT Provider AB (Publ) is not a licensed financial advisor. The views presented in this release are the opinions of the Board of XBT Provider AB (Publ) and no other party. Bitcoin and ether are volatile assets and their prices (and the price of securities that are referenced to them) can move quickly. Prospective investors in the Issuer's certificates should carefully consider the suitability of such an investment and, in connection with such a determination, should carefully read the Issuer's latest Prospectus (including, in particular, the risk warnings set out therein). For More Information regarding XBT Provider, contact us at: XBT Provider AB (Publ) info@XBTProvider.com or visit our website at: www.XBTProvider.com 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fannie Mae Q3 2026 Earnings Surpass Expectations

Updated Category News Views 116

An Upward Trend in Fannie Mae's Financials Hold onto your hats—Fannie Mae's swinging into action with hefty third-quarter numbers that'd make most firms drool. The latest figures, disclosed in their 10-Q filing, boast a net income of $4.2 billion for Q3 2026. You heard me right, billion! Now, to a market vet, these aren't digits to scoff at. And as the economy keeps...

Continue Reading
Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

Updated Category News Views 67

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....

Continue Reading
Tabañero Spices Up Holidays with $10 Gift Sets

Updated Category News Views 120

Hot Sauce, Spicy Gifting, and Bold Barbecue When holiday cheer mixes with a dash of heat, you end up with something as electrifying as Tabañero's latest offerings. This Florida-based player is nudging its way into the gift-giving scene with a lineup that's as spicy as it is thoughtful. Frankly, if you're scrambling for stocking stuffers or a memorable Secret Santa...

Continue Reading
E-Bike Demo Day Spurs New Jersey's Policy Insights

Updated Category News Views 88

Velotric Sets the Stage for E-Bike Insights The chatter over at Trenton has been electric—and I mean that literally. On October 29, Assemblywoman Tennille R. McCoy will open the gates of the New Jersey State House to host an E-Bike Demonstration and Education Day. The goal? To slap some sense into lawmakers' understanding of the buzzing e-bike market. Velotric, a major...

Continue Reading
Keeping Halloween Safe and Fun with AHN Tips

Updated Category News Views 95

Trick or Treat the Safe Way Ah, Halloween. A time when you don't just get to pretend to be someone else; you get to pile on the candy like it's a second job. But hold up! Before your pint-sized Dracula sprints into the foggy night, heed some wisdom from the folks at Allegheny Health Network. They aren't just offering another bowl of sugar-coated advice; they've got...

Continue Reading
Sol Taps Silberman: Bold New Era for Marketing Shift

Updated Category News Views 153

Bringing Media Savvy to AI Strategy Dan Silberman, the seasoned media executive from A+E Global Media, just jumped ship to helm marketing and communications at Sol, a firm peddling its ware in AI-enabled business transformation. Maybe you're scratching your head, wondering why the heck it matters. Well, as I see it, this ain't just another name change on a corporate...

Continue Reading
Uwharrie Capital's 2026 Q3 Shows Steady Growth

Updated Category News Views 79

Uwharrie Capital's Financial Dance Well, don't dust off the neon ticker tape quite yet but Uwharrie Capital Corp (OTCQX:UWHR) gave us a reason to nod approvingly over our espresso this quarter. From a scrappy hometown operation to a regional bank showing its mettle, the numbers they've laid down ain't half bad. Assets Climb a Billion-Dollar Ladder First thing that jumps...

Continue Reading
Hehe Forum Stirs Global Harmony in Taizhou, China

Updated Category News Views 70

Reflecting on Hehe Culture's Impact Seems like everyone and their neighbor are flocking to Taizhou for the annual Hehe Culture Forum. It's not your run-of-the-mill gathering; more than 220 folks from 23 different countries showed up, diving deep into the murky waters of cultural exchange, global governance, and international cooperation. Now, if you think it's just...

Continue Reading
Unity Crucial for Global South's Economic Gains

Updated Category News Views 37

Anytime you hear the 'Global South' being bandied about these days, you know someone's talking about the clout shifting in the world. In Beijing this week, they were hashing out how these nations can crank up their collective volume on the global stage. Gathering Brains in Beijing At the Global Strategic Dialogue 2026, held slap-bang in Beijing, experts and high-profile...

Continue Reading
Biopharma Rethinks Strategy Amid U.S. MFN Pricing Shift

Updated Category News Views 128

Global Pharma Grapples with U.S. MFN Pricing Sometimes, regulatory changes hit the industry like a freight train, and other times they creep in like the tide reshaping everything without much fanfare. The U.S. Most-Favored-Nation (MFN) pricing rule, spotlighted in a recent World ACCESS Consortium (WAC) white paper, might be the latter. It’s bending biopharmaceuticals'...

Continue Reading

Top 5 Most Recently Viewed Articles

Tenet® Beef: Revolutionizing Tenderness in America's Steaks

Updated Category News Views 30

Cracking the Code: A Genetic Leap in Beef Tenderness Well, buckle up, folks, because Callipyge Genetics is shaking things up in the beef aisle with their genomic breakthrough, Tenet®. It's about time we see some real innovation in an industry that's, let's face it, been slow to evolve. This isn't just a flash in the pan—a bit of DNA parsing has uncovered how to...

Continue Reading
Investigation of CNB Bank Shares: Your Rights as a Shareholder

Updated Category News Views 244

Investigation of CNB Bank Shares Inc. Transactions Recently, the M&A Class Action Firm has launched an investigation regarding CNB Bank Shares, Inc. (OTCMKTS: CNBN) due to its proposed sale to HBT Financial, Inc. This inquiry seeks to determine if the deal being offered to shareholders is fair and just. When a company is involved in such significant transactions, it...

Continue Reading
Strategies for Trading SPY and Top Tech Stocks Effectively

Updated Category News Views 162

Analyzing Market Dynamics for Effective Trading Good morning traders! As we dive into this exciting trading day, it’s crucial to understand the key dynamics that may influence the market. Key Economic Indicators Impacting Trading The ADP Employment report, coming at 8:15 AM ET, serves as an initial glimpse into private payrolls, shaping our expectations for official...

Continue Reading
aTyr Pharma Faces Legal Backlash After Drug Trial Failure

Updated Category News Views 174

aTyr Pharma's Recent Legal Struggles In a notable case in the biotech sector, aTyr Pharma, Inc. (NASDAQ: ATYR) is currently grappling with significant legal challenges following an alarming 83% decline in its stock price. This dramatic turn stems from the company's lead drug candidate's failure in a critical Phase 3 trial. Such setbacks can have profound...

Continue Reading
JFrog Ltd. (FROG) Faces Scrutiny as Investigation Unfolds

Updated Category News Views 359

Investigation of JFrog Ltd. (FROG) by Law Offices of Howard G. Smith The Law Offices of Howard G. Smith is actively investigating JFrog Ltd. (“JFrog” or the “Company”) (NASDAQ: FROG) on behalf of its investors. This investigation centers around potential violations of federal securities laws that may have affected shareholders. Recent Financial Performance and...

Continue Reading